The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

NDUFB6  -  NADH dehydrogenase (ubiquinone) 1 beta...

Homo sapiens

Synonyms: B17, CI, CI-B17, Complex I-B17, NADH-ubiquinone oxidoreductase B17 subunit
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of NDUFB6

  • The inserted DNA was expressed in Escherichia coli transformants as a polypeptide fused to the lambda CI protein at its amino terminus and to beta-galactosidase at its carboxyl terminus [1].
  • CONCLUSION: The CI regimen was virtually identical to CIB with regard to response rate, PFS, survival, and toxicity profile [2].
  • NADH dehydrogenase or complex I (CI) is affected in most of the mitochondrial diseases and in some neurodegenerative disorders [3].
  • METHODS: CI secretion and steady-state pro alpha1(I) collagen messenger RNA (mRNA) levels and COL1A2 gene activation were examined in fibroblasts grown from lung biopsy specimens obtained from 16 scleroderma patients with lung fibrosis and from 10 histologically normal lung specimens (controls) [4].
  • Cleavage of bacteriophage phi 80 CI repressor by RecA protein [5].
 

Psychiatry related information on NDUFB6

 

High impact information on NDUFB6

 

Biological context of NDUFB6

 

Anatomical context of NDUFB6

  • Transient expression assays confirmed that genes coding for CI are transcriptionally activated in scleroderma lung fibroblasts compared with control strains [4].
  • The idiotype is identified with antisera and monoclonal antibodies prepared against the IgM (kappa) antibody secreted by the Epstein-Barr virus-transformed human B cell line B17 [12].
  • We have used this probe and Southern blotting techniques to identify the human apo CI gene in DNA from a series of rodent X human somatic cell hybrids [13].
  • When administered orally, the CI fusion protein induced efficient immunological suppression of ovalbumin-specific T-cell responses in mice co-immunized parenterally with insulin and ovalbumin [14].
  • A human-human hybridoma producing cytotoxic antibody to HLA-B15, cross-reacting with B17, B5, B35 and B18 [15].
 

Associations of NDUFB6 with chemical compounds

  • Both culture compartments contain a large chondroitin sulfate proteoglycan (MI, CI) that eluted in the void volume of a Sepharose CL-4B column and contained glycosaminoglycan chains of molecular weight (mol wt) approximately 38,000 [16].
  • Meanwhile, in vitro studies with microcin B17 have helped to uncover the molecular mechanisms by which post-translational modification results in the formation of heterocyclic oxazole and thiazole rings [17].
  • Two arginine residues in positions B13 and B17 that project like forefinger and middle finger from the helix provide the electrostatic element opposed by the hydrophobic (thumb) element isoleucine (B20), offset from the arginines by about 40 degrees [18].
  • Members of the B17 family share a preference for peptides with serine, threonine, or alanine at position 2 and aromatic residues at the carboxyl terminus [19].
  • The derivative in which the two arginines in positions B13 and B17 had been replaced by the uncharged isosteric amino acid citrulline were biologically inactive [20].
 

Other interactions of NDUFB6

 

Analytical, diagnostic and therapeutic context of NDUFB6

  • RESULTS: There were no significant differences between CI and CIB with regard to response rates (32% v 31.2%, respectively), progression-free survival (PFS), or overall survival [2].
  • The HLA-B17 cross-reactive group and the participation of the subdivisions of B17 ( Bw57 and Bw58 ) in cross-reactivity were investigated by the serological analysis of 81 cytotoxic HLA antisera (produced by pregnancy alone), the HLA typing of the antiserum donors and the identification of their immunizing antigens [22].
  • The B17 alleles were identified from genomic DNA using group-specific polymerase chain reaction (PCR) followed by hybridization with sequence-specific oligonucleotide probes (SSOP) [23].
  • Here, we report correlation of DNA typing results with serological and IEF results for the B17 group [24].
  • In addition, we demonstrate that the CI fusion protein induces efficient immunosuppression after oral administration, raising the possibility of using such constructs in the treatment of type-1 diabetes [14].

References

  1. Expression in Escherichia coli of open reading frame gene segments of HTLV-III. Chang, N.T., Chanda, P.K., Barone, A.D., McKinney, S., Rhodes, D.P., Tam, S.H., Shearman, C.W., Huang, J., Chang, T.W., Gallo, R.C. Science (1985) [Pubmed]
  2. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study. Bloss, J.D., Blessing, J.A., Behrens, B.C., Mannel, R.S., Rader, J.S., Sood, A.K., Markman, M., Benda, J. J. Clin. Oncol. (2002) [Pubmed]
  3. Titrating the effects of mitochondrial complex I impairment in the cell physiology. Barrientos, A., Moraes, C.T. J. Biol. Chem. (1999) [Pubmed]
  4. Scleroderma lung fibroblasts exhibit elevated and dysregulated type I collagen biosynthesis. Shi-Wen, X., Denton, C.P., McWhirter, A., Bou-Gharios, G., Abraham, D.J., du Bois, R.M., Black, C.M. Arthritis Rheum. (1997) [Pubmed]
  5. Cleavage of bacteriophage phi 80 CI repressor by RecA protein. Eguchi, Y., Ogawa, T., Ogawa, H. J. Mol. Biol. (1988) [Pubmed]
  6. The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease. Yu, C.E., Payami, H., Olson, J.M., Boehnke, M., Wijsman, E.M., Orr, H.T., Kukull, W.A., Goddard, K.A., Nemens, E., White, J.A. Am. J. Hum. Genet. (1994) [Pubmed]
  7. Cotranslocational insertion of apolipoprotein B into the inner leaflet of the endoplasmic reticulum. Pease, R.J., Harrison, G.B., Scott, J. Nature (1991) [Pubmed]
  8. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Lu, S.J., Day, N.E., Degos, L., Lepage, V., Wang, P.C., Chan, S.H., Simons, M., McKnight, B., Easton, D., Zeng, Y. Nature (1990) [Pubmed]
  9. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Inoue, N., Kawashima, S., Kanazawa, K., Yamada, S., Akita, H., Yokoyama, M. Circulation (1998) [Pubmed]
  10. Microcin B17: posttranslational modifications and their biological implications. Liu, J. Proc. Natl. Acad. Sci. U.S.A. (1994) [Pubmed]
  11. Molecular characterization and mutational analysis of the human B17 subunit of the mitochondrial respiratory chain complex I. Smeitink, J., Loeffen, J., Smeets, R., Triepels, R., Ruitenbeek, W., Trijbels, F., van den Heuvel, L. Hum. Genet. (1998) [Pubmed]
  12. A cross-reacting human idiotype (B17) associated with antibodies to N-acetyl-D-glucosamine. Specificity, immunoglobulin class association, and distribution in the population. Emmrich, F., Greger, B., Eichmann, K. Eur. J. Immunol. (1983) [Pubmed]
  13. Isolation and characterisation of a cDNA clone for human apolipoprotein CI and assignment of the gene to chromosome 19. Tata, F., Henry, I., Markham, A.F., Wallis, S.C., Weil, D., Grzeschik, K.H., Junien, C., Williamson, R., Humphries, S.E. Hum. Genet. (1985) [Pubmed]
  14. Genetic fusion of human insulin B-chain to the B-subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo. Sadeghi, H., Bregenholt, S., Wegmann, D., Petersen, J.S., Holmgren, J., Lebens, M. Immunology (2002) [Pubmed]
  15. A human-human hybridoma producing cytotoxic antibody to HLA-B15, cross-reacting with B17, B5, B35 and B18. Hansen, T., Kolstad, A., Thorsby, E., Hannestad, K. Tissue Antigens (1987) [Pubmed]
  16. Proteoglycans in human long-term bone marrow cultures: biochemical and ultrastructural analyses. Wight, T.N., Kinsella, M.G., Keating, A., Singer, J.W. Blood (1986) [Pubmed]
  17. Lantibiotics and microcins: polypeptides with unusual chemical diversity. Jack, R.W., Jung, G. Current opinion in chemical biology. (2000) [Pubmed]
  18. The relaxin receptor-binding site geometry suggests a novel gripping mode of interaction. Büllesbach, E.E., Schwabe, C. J. Biol. Chem. (2000) [Pubmed]
  19. Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity. Barber, L.D., Percival, L., Arnett, K.L., Gumperz, J.E., Chen, L., Parham, P. J. Immunol. (1997) [Pubmed]
  20. Total synthesis of human relaxin and human relaxin derivatives by solid-phase peptide synthesis and site-directed chain combination. Büllesbach, E.E., Schwabe, C. J. Biol. Chem. (1991) [Pubmed]
  21. Clinical and genetic heterogeneity in chromosome 9p associated hereditary inclusion body myopathy: exclusion of GNE and three other candidate genes. Watts, G.D., Thorne, M., Kovach, M.J., Pestronk, A., Kimonis, V.E. Neuromuscul. Disord. (2003) [Pubmed]
  22. A serological study of the HLA-B17 cross-reactive group. Darke, C. Tissue Antigens (1984) [Pubmed]
  23. Diversity of HLA-B17 alleles and haplotypes in East Asians and a novel Cw6 allele (Cw*0604) associated with B*5701. Inoue, T., Ogawa, A., Tokunaga, K., Ishikawa, Y., Kashiwase, K., Tanaka, H., Park, M.H., Jia, G.J., Chimge, N.O., Sideltseva, E.W., Akaza, T., Tadokoro, K., Takahashi, T., Juji, T. Tissue Antigens (1999) [Pubmed]
  24. Allelic frequencies of the HLA-B17 antigen group: comparative analysis by serology, IEF and PCR-SSOP typing. Levine, J.E., Yang, S.Y. Tissue Antigens (1995) [Pubmed]
 
WikiGenes - Universities